Document is current
Any future updates will be listed below
-
Authors
Wu, Gengrun
Li, Teng
Chen, Yuanbiao
Ye, Shiqi
Zhou, Siqi
Tian, Xi
Anwaier, Aihetaimujiang
Zhu, Shuxuan
Xu, Wenhao
Hao, Xiaohang
Ye, Dingwei
Zhang, Hailiang
-
Funding
Funding for this research was provided by:
"Fuqing Scholar" Student Scientific Research Program of Shanghai Medical College, Fudan University (No. FQXZ202304A)
Shanghai Anticancer Association EYAS PROJECT (SACA-CY23A02 and SACA-CY23C04)
Shanghai Anticancer Association EYAS PROJECT (SACA-CY23A02 and SACA-CY23C04)
Shanghai Municipal Health Bureau Project (No. 2020CXJQ03)
Beijing Xisike Clinical Oncology Research Foundation (No. Y-HR2020MS-0948)
China Anti-Cancer Association- Hengrui PARP Nicotinamide Cancer Research Fund (CETSDHRCORP252-4-021)
- License Information
-
More Information
Article History
Received: 20 April 2024
Accepted: 5 June 2024
First Online: 6 July 2024
Declarations
:
: The authors declare no competing interests.
: Approval was obtained from the ethics committee of Fudan University Shanghai Cancer Center. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
